Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen and arginine gel for sensitivity after dental whitening
RBR-8skkj7qPhase 2Completed
- Sponsor
- Univel
- Start
- Jan 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ibuprofen and arginine in Dentinal hypersensitivity (DH) (2 arms), sponsored by Univel. Primary endpoints: Dentin sensitivity during whitening and Dentin sensitivity after whitening. Started Jan 2025; status: completed.
02
Drugs
ibuprofenarginine
03
Conditions
Dentinal hypersensitivity (DH)
Beyond the preview
Go deeper on RBR-8skkj7q.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8skkj7q.